Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes. Reply

Rajiv Agarwal, Peter Rossing, Johannes F E Mann

1 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	The New England journal of medicine
Vol/bind	393
Udgave nummer	17
Sider (fra-til)	1755
Antal sider	1
ISSN	0028-4793
DOI	https://doi.org/10.1056/NEJMc2513088
Status	Udgivet - 30 okt. 2025

Adgang til dokumentet

@article{14bcb21d0f174ed29dbfb9f0e0a8b4ae,

title = "Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes. Reply",

author = "Rajiv Agarwal and Peter Rossing and Mann, {Johannes F E}",

year = "2025",

month = oct,

day = "30",

doi = "10.1056/NEJMc2513088",

language = "English",

volume = "393",

pages = "1755",

journal = "The New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "17",

}

TY - JOUR

T1 - Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes. Reply

AU - Agarwal, Rajiv

AU - Rossing, Peter

AU - Mann, Johannes F E

PY - 2025/10/30

Y1 - 2025/10/30

UR - http://www.scopus.com/inward/record.url?scp=105020480426&partnerID=8YFLogxK

U2 - 10.1056/NEJMc2513088

DO - 10.1056/NEJMc2513088

M3 - Editorial

C2 - 41160832

SN - 0028-4793

VL - 393

SP - 1755

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 17

ER -